Ascendis Pharma A/S (NASDAQ:ASND) vs. Kalaris Therapeutics (NASDAQ:KLRS) Head-To-Head Comparison

Chronological Source Flow
Back

AI Fusion Summary

Kalaris Therapeutics: sell, hold, 4 buy, strong buy, $14 target, 129% upside; Ascendis Pharma A/S: sell, 17 buy, strong buy. Australian Oilseeds: no margin data, beta 0.08; Campbell’s: 5.48% net margin, 19.96% ROE, 5.21% ROA, beta 0.03.
#KALARIS_THERAPEUTICS #ASCENDEIS_PHARMA #AUSTRALIAN_OILSEEDS #CAMPBELL #ANALYST_RATINGS #FINANCIAL_METRICS
25/04 10:40 defenseworld.net
2 Πηγές

Ascendis Pharma A/S (NASDAQ:ASND) vs. Kalaris Therapeutics (NASDAQ:KLRS) Head-To-Head Comparison

COMPANIESPOLITICSCOMPARISON ARTICLES
25/04 10:48 defenseworld.net

Head to Head Comparison: Australian Oilseeds (NASDAQ:COOT) and Campbell’s (NASDAQ:CPB)

POLITICSCOMPANIESCOMPARISON ARTICLES
Comments
Loading...
0